Abstract
To formulate evidence based recommendations on vaccinating male individuals against human papillomavirus (HPV). A research with the keywords “hpv”, “vaccination” and “men” was performed for published articles on the last ten years, on Portuguese and English languages, on the following data bases: PubMed, National Guidelines Cleringhouse, Guidelines Finder, CMA Infobase, Cochrane, DARE and BMJ. Thirteen documents were obtained and the recommendations’ analysis was conducted according to the Strength Of Recommendation Taxonomy (SORT) system. From the five reviews, seven consensus and one guideline that were found, the following recommendations on vaccinating male individuals against HPV were obtained. Routine vaccination should be performed on all individuals at 11 or 12 years old (C). Vaccination is recommended until the age of 21 years old, if not vaccinated previously (C). Vaccination of men who have sex with men (MSM) is recommended until the age of 26 years old (B). Vaccination is recommended on all immunocompromised individuals (B). Vaccination is recommended on all HIV-infected individuals (B).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
